| Quarter | Score |
|---|---|
| 2022-Q1 | 49.5 |
| 2022-Q3 | 42.2 |
| 2022-Q4 | 49.6 |
| 2023-Q1 | 49.0 |
| 2023-Q2 | 65.2 |
| 2023-Q3 | 48.0 |
| 2023-Q4 | 36.0 |
| 2024-Q1 | 70.3 |
| 2024-Q2 | 70.6 |
| 2024-Q3 | 57.6 |
| 2024-Q4 | 57.7 |
| 2025-Q1 | 58.7 |
| 2025-Q2 | 82.1 |
| 2025-Q3 | 86.2 |
| 2025-Q4 | 86.2 |
| 2026-Q1 | 83.9 |
| 2026-Q2 | 76.0 |
Funds reducing exposure or consensus momentum fading
Trading +60.7% above funds' purchase price — elevated pullback risk
2 of 18 tracked funds hold MDB. Avg conviction: 0.5%. Net trimming. First tracked at $240.17 (current +60.7% vs tracked).
ValueAct Capital has 1.0% in this stock
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 17 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|---|---|
| ValueAct Capital | 1.0% | Reduce |
| Citadel Advisors | 0.0% | Reduce |